United States

People: Texas Instruments Inc (TXN.OQ)

TXN.OQ on NASDAQ Stock Exchange Global Select Market

26 Jun 2017
Change (% chg)

$-1.27 (-1.60%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Cox, Carrie 

Ms. Carrie S. Cox is an Independent Director of Texas Instruments Incorporated. She has been chairman (2013-present), CEO and a director (2010-present) of Humacyte, Inc., executive vice president and president of Global Pharmaceuticals at Schering-Plough Corporation (2003-2009) and executive vice president and president of Global Prescription Business at Pharmacia Corporation (1997-2003), has gained first-hand experience in managing large, multinational organizations focused on medical-related markets, with responsibility for those organizations’ financial performance and significant capital and R&D investments. Is also a director of Cardinal Health, Inc. (2009-present) and Celgene Corporation (2009-present).

Basic Compensation

Total Annual Compensation, USD 85,000
Restricted Stock Awards, USD 99,985
Long-Term Incentive Plans, USD --
All Other, USD 112,355
Fiscal Year Total, USD 297,340

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --